UM
T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities
Wang Y.; Yang Y.-S.; Tang X.-C.; Zhang H.-Y.
2011-09-01
Source PublicationActa Pharmacologica Sinica
ISSN16714083 17457254
Volume32Issue:9Pages:1100-1108
AbstractAim:To examine the neuroprotective effects of T33, a peroxisome proliferator-activated receptor gamma/alpha (PPARγ/α) agonist, in acute ischemic models in vitro and in vivo.Methods:Primary astrocytes subjected to oxygen-glucose deprivation/reperfusion (O/R) and BV-2 cells subjected to hypoxia were used as a model simulating the ischemic core and penumbra, respectively. The m RNA levels of tumor necrosis factor-α (TNF-α) and interleukin-1Β (IL-1Β) were measured using q PCR. The levels of TNF-α secreted by BV-2 cells were measured using ELISA. Protein levels of cyclooxygenase-2 (COX-2), p65, phosphorylated I-Bα/I-Bα, phosphorylated I-B kinase (p IKK), phosphorylated eukaryote initiation factor 2α (p-e IF-2α)/e IF-2α and p-p38/p38 were detected using Western blot. PPARγ activity was measured using EMSA. The neuroprotection in vivo was examined in rat middle cerebral artery occlusion (MCAO) model with neurological scoring and TTC staining.Results:Addition of T33 (0.5 mol/L) increased the level of I-Bα protein in primary astrocytes subjected to O/R, which was due to promoting protein synthesis without affecting degradation. In primary astrocytes subjected to O/R, addition of T33 amplified I-Bα gene transcription and m RNA translation, thus suppressing the nuclear factor-kappa B (NF-B) pathway and reducing inflammatory mediators (TNF-α, IL-1Β, and COX-2). In BV-2 cells subjected to hypoxia, T33 (0.5 mol/L) reduced TNF-α, COX-2, and p-P38 production, which was antagonized by pre-administration of the specific PPARγ antagonist GW9662 (30 mol/L). T33 (2 mg/kg, ip) attenuated MCAO-induced inflammatory responses and brain infarction, which was antagonized by pre-administered GW9662 (4 mg/kg, ip).Conclusion:T33 exerted anti-inflammatory effects in the ischemic core and penumbra via PPARγ activation, which contributed to its neuroprotective action. © 2011 CPS and SIMM. All rights reserved.
Keywordastrocytes BV-2 cells inflammation middle cerebral artery occlusion nuclear factorkappa B oxygen-glucose deprivation peroxisome proliferator-activated receptor γ stroke T33
DOI10.1038/aps.2011.69
URLView the original
Language英語
全文获取链接
引用统计
被引频次[WOS]:4   [WOS记录]     [WOS相关记录]
Document TypeJournal article
专题University of Macau
AffiliationShanghai Institute of Materia Medica, Chinese Academy of Sciences
推荐引用方式
GB/T 7714
Wang Y.,Yang Y.-S.,Tang X.-C.,et al. T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities[J]. Acta Pharmacologica Sinica,2011,32(9):1100-1108.
APA Wang Y.,Yang Y.-S.,Tang X.-C.,&Zhang H.-Y..(2011).T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities.Acta Pharmacologica Sinica,32(9),1100-1108.
MLA Wang Y.,et al."T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities".Acta Pharmacologica Sinica 32.9(2011):1100-1108.
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
Google Scholar
中相似的文章 Google Scholar
[Wang Y.]的文章
[Yang Y.-S.]的文章
[Tang X.-C.]的文章
Baidu academic
中相似的文章 Baidu academic
[Wang Y.]的文章
[Yang Y.-S.]的文章
[Tang X.-C.]的文章
Bing Scholar
中相似的文章 Bing Scholar
[Wang Y.]的文章
[Yang Y.-S.]的文章
[Tang X.-C.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。